胰岛素,糖尿病 z-bo 2020-09-18 421

　　Researchers at the University of Utah in the United States said that a 14-hour experimental drug "smart insulin" has shown results in mice, and it is expected to be tested on type 1 diabetes patients within two years.

　　The research results published in the Proceedings of the National Academy of Sciences of the United States pointed out that Ins-PBA-F, developed by a student chemist at the University of Utah, can be activated by itself when blood sugar rises. The study pointed out that tests on type 1 diabetic mice showed that after giving them the sugar equivalent to a meal, an injection of Ins-PBA-F can continuously and automatically lower blood sugar.

　　This drug closely mimics how normal mice reduce blood sugar back to normal levels after eating. The researchers said: "This is a very important advancement in insulin therapy. Our insulin derivatives seem to control blood sugar better than any therapies currently available to diabetics."

　　Patients with type 1 diabetes must constantly monitor their blood glucose levels and manually inject insulin when necessary. Any failure or delay may cause serious complications, including heart disease, blindness, and even death.